Henry Ford Health System Study: Hydroxychloroquine Lowers COVID-19 Death Rate
Henry Ford Health System Study: Hydroxychloroquine Lowers COVID-19 Death Rate
You got this! You know what symptoms are, you know your own body, you can get a test if you really want one.
And yes, there are antivirals that will really help should you test positive. Just don't wait until your blood oxygen is down to 80%!
BTW, if you wore your mask and even half of the others did - given the volume of air in Home Depot, you were in fact fairly safe (not zero though - but pretty close).
More about that here.
The Lancet retracts large study on hydroxychloroquine
"A first-year statistics major could tell you about major flaws in the design of the analysis," one expert said.
Study finds hydroxychloroquine treatment associated with lower mortality rate for COVID-19 patients
And remember this? There was much criticism of the President for promoting hydroxychloroquine. Turns out he was right. IMO
Ignoring Expert Opinion, Trump Again Promotes Use of Hydroxychloroquine
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19Gosh I wish they'd publish this and we could see the actual peer review. I go through dozens and dozens of studies per day - and don't even bother to look at ones without randomized trials.
There's no citation, there's a claim of peer review. I guess I'll have to go look by author. But it's really rare for a hospital to deny what it thinks is a good drug to half its patients - so the research protocol needs to be published.
Of note (and of great interest) is their claim that early use of HCQ helps and that they used a different dosage than any other study.
So where's their help to the medical community? Can they not say where they published or what the dosage was? Higher or lower? I think that's pretty important (and was it the same or titrated in the chosen group - and how did they choose the groups??)
There's study after study without proper controls, here's one recent one:
COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study
It makes HCQ sound promising - but HCQ wasn't the only drug administered (it rarely is). But in this case of somewhat successful use of HCQ (no where near the claims of the newspaper article in the link), it was low dose and combined with something else. Isn't that something else possibly inportant?
The something else is Zinc - which, by itself, is shown to have an effect on mortality.
Did the Ford people use ZInc or not? (I believe they did, I cannot believe they didn't - it doesn't make medical sense to me). But if they really did a control on HCQ without Zinc, I would like to know in whose hands the pre-print currently may reside.
The purpose of this study was to evaluate the role of hydroxychloroquine therapy alone and in combination with azithromycin in hospitalized patients positive for COVID-19.
San Antonio TX calling in military medical personnel to help with COVID.
Strangely enough, this directly conflicts with the FDA.
July 1, 2020 Update: A summary of the FDA review of safety issues with the use of hydroxychloroquine and chloroquine to treat hospitalized patients with COVID-19 is now available. This includes reports of serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.
June 15, 2020 Update: Based on ongoing analysis and emerging scientific data, FDA has revoked the emergency use authorization (EUA) to use hydroxychloroquine and chloroquine to treat COVID-19 in certain hospitalized patients when a clinical trial is unavailable or participation is not feasible. We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19.
FDA cautions use of hydroxychloroquine/chloroquine for COVID-19
Stephanie Innes
@stephanieinnes
The Harvard Global Health Institute 2day has 4 states in the highest risk #COVID19 "red zone" - #Arizona, Florida, South Carolina & Louisiana, based on 7-day average of new cases/100K. Institute says in red zone, stay-at-home orders are "necessary"
Gosh I wish they'd publish this and we could see the actual peer review. I go through dozens and dozens of studies per day - and don't even bother to look at ones without randomized trials.
There's no citation, there's a claim of peer review. I guess I'll have to go look by author. But it's really rare for a hospital to deny what it thinks is a good drug to half its patients - so the research protocol needs to be published.
Of note (and of great interest) is their claim that early use of HCQ helps and that they used a different dosage than any other study.
So where's their help to the medical community? Can they not say where they published or what the dosage was? Higher or lower? I think that's pretty important (and was it the same or titrated in the chosen group - and how did they choose the groups??)
There's study after study without proper controls, here's one recent one:
COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study
It makes HCQ sound promising - but HCQ wasn't the only drug administered (it rarely is). But in this case of somewhat successful use of HCQ (no where near the claims of the newspaper article in the link), it was low dose and combined with something else. Isn't that something else possibly inportant?
The something else is Zinc - which, by itself, is shown to have an effect on mortality.
Did the Ford people use ZInc or not? (I believe they did, I cannot believe they didn't - it doesn't make medical sense to me). But if they really did a control on HCQ without Zinc, I would like to know in whose hands the pre-print currently may reside.
No mention of zinc in the article.
Strangely enough, this directly conflicts with the FDA.
July 1, 2020 Update: A summary of the FDA review of safety issues with the use of hydroxychloroquine and chloroquine to treat hospitalized patients with COVID-19 is now available. This includes reports of serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.
June 15, 2020 Update: Based on ongoing analysis and emerging scientific data, FDA has revoked the emergency use authorization (EUA) to use hydroxychloroquine and chloroquine to treat COVID-19 in certain hospitalized patients when a clinical trial is unavailable or participation is not feasible. We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19.
FDA cautions use of hydroxychloroquine/chloroquine for COVID-19
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext
More about that here.
The Lancet retracts large study on hydroxychloroquine
"A first-year statistics major could tell you about major flaws in the design of the analysis," one expert said.
Study finds hydroxychloroquine treatment associated with lower mortality rate for COVID-19 patients
And remember this? There was much criticism of the President for promoting hydroxychloroquine. Turns out he was right. IMO
Ignoring Expert Opinion, Trump Again Promotes Use of Hydroxychloroquine
Has anyone heard which antivirals are used for prophylaxis for exposure?
This is why we need to not make decisions based on politics. Trump grasped on to news of the French study in the hopes that it would work.
In this study, which is fairly large, it does appear to. Why not at least discuss and explore using everything in our toolbox that might work?
Antivirals.
Malaria drugs
Zinc
Arythromyocin (sp.?)
Etc.
The study explains that the drug needs to only be given in a hospital setting with the patients’ hearts closet monitored and that it helps when given early rather than later.
I think the entire world is grasping at anything hoping it will work.
I think the entire world is grasping at anything hoping it will work.
We use essential cookies to make this site work, and optional cookies to enhance your experience.